Attached files
file | filename |
---|---|
EX-31.2 - EXHIBIT 31.2 - INTERMOLECULAR INC | ex312_cfox10k.htm |
EX-32.2 - EXHIBIT 32.2 - INTERMOLECULAR INC | ex322_cfox10k.htm |
EX-31.1 - EXHIBIT 31.1 - INTERMOLECULAR INC | ex311_ceox10k.htm |
EX-10.39 - EXHIBIT 10.39 - INTERMOLECULAR INC | ex1039_griffinxagreement.htm |
EX-10.40 - EXHIBIT 10.40 - INTERMOLECULAR INC | ex1040_separationagreement.htm |
EX-10.42 - EXHIBIT 10.42 - INTERMOLECULAR INC | ex1042_separationagreement.htm |
EX-10.41 - EXHIBIT 10.41 - INTERMOLECULAR INC | ex1041_separationagreement.htm |
EX-10.37 - EXHIBIT 10.37 - INTERMOLECULAR INC | ex1037_guardianxamendment4.htm |
EX-10.38 - EXHIBIT 10.38 - INTERMOLECULAR INC | ex1038_mcwilliamsxagreement.htm |
EXCEL - IDEA: XBRL DOCUMENT - INTERMOLECULAR INC | Financial_Report.xls |
10-K - 10-K - INTERMOLECULAR INC | a10k-20141231.htm |
EX-32.1 - EXHIBIT 32.1 - INTERMOLECULAR INC | ex321_ceox10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Intermolecular, Inc.:
We consent to the incorporation by reference in the registration statement (No. 333-178154, 333-180169, 333-187017 and 333-194464) on Form S-8 of Intermolecular, Inc. of our reports dated February 27, 2015, with respect to the consolidated balance sheets of Intermolecular, Inc. and subsidiaries as of December 31, 2014 and 2013, and the related consolidated statements of operations, comprehensive loss, stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2014, and the effectiveness of internal control over financial reporting as of December 31, 2014, which reports appear in the December 31, 2014 annual report on Form 10-K of Intermolecular, Inc.
/s/ KPMG LLP
Santa Clara, California
February 27, 2015
February 27, 2015